Future proofing

NICE annual review 2017-18

Scroll down for more

Illustration showing different types of medicine.

Transforming NICE's technology guidance and advice

In 2017/18, we implemented changes to our technology appraisal programme to better align it to the challenges the NHS is facing and the needs of the life sciences industry.

In January 2018, we published our 500th technology appraisal.

Changes introduced from April 2018 will facilitate earlier engagement between NICE, companies and NHS England, intended to reduce delays later in the process and to support commercial discussions when they are required. They build on the introduction of the budget impact test, in 2017, which triggers the opportunity for a discussion between companies and NHS England, to help manage the introduction of high-budget-impact technologies recommended by NICE.

Abstract image with connecting lines and different colours.

A collection of pills and tablets.
Image of cancer cells.

Cancer Drugs Fund

March 2018 marked the second anniversary of NICE and NHS England implementing a new model for the Cancer Drugs Fund (CDF).

By using the CDF to fund promising cancer treatments, patients get access to promising and innovative cancer drugs faster than ever before.

TopBuilt with Shorthand